External Validation of Mortality Prediction Models for Critical Illness Reveals Preserved Discrimination but Poor Calibration

Cox, E. G. M., Wiersema, R., Eck, R. J., Kaufmann, T., Granholm, A., Vaara, S. T., Møller, M. H., Van Bussel, B. C. T., Snieder, H., Pleijhuis, R. G., Van Der Horst, I. C. C. & Keus, F., 1-jan.-2023, In: Critical Care Medicine. 51, 1, blz. 80-90 11 blz.

Onderzoeksoutput › Academic › peer review

Anticoagulants for thrombosis prophylaxis in acutely ill patients admitted to hospital: systematic review and network meta-analysis

Eck, R. J., Elling, T., Sutton, A. J., Wetterslev, J., Gluud, C., van der Horst, I. C. C., Gans, R. O. B., Meijer, K. & Keus, F., 4-jul.-2022, In: BMJ (Clinical research ed.). 378, blz. e070022

Onderzoeksoutput › Academic › peer review

Management of acute atrial fibrillation in the intensive care unit: An international survey

the AFIB-ICU collaborators, Wetterslev, M., Møller, M. H., Granholm, A., Hassager, C., Haase, N., Aslam, T. N., Shen, J., Young, P. J., Aneman, A., Hästbacka, J., Siegemund, M., Cronhjort, M., Lindqvist, E., Myatra, S. N., Kalvit, K., Arabi, Y. M., Szczeklik, W., Sigurdsson, M. I., Balik, M., & 2 anderenKeus, F. & Perner, A., mrt.-2022, In: Acta Anaesthesiologica Scandinavica. 66, 3, blz. 375-385 11 blz.

Onderzoeksoutput › Academic › peer review

Trough anti-Xa activity after intermediate dose nadroparin for thrombosis prophylaxis in critically ill patients with COVID-19 and acute kidney injury

Eck, R. J., van de Leur, J. J. C. M., Wiersema, R., Cox, E. G. M., Bult, W., Spanjersberg, A. J., van der Horst, I. C. C., Lukens, M., Gans, R. O. B., Meijer, K. & Keus, F., 18-okt.-2022, In: Scientific Reports. 12, 1, 9 blz., 17408.

Onderzoeksoutput › Academic › peer review